HomeComparePZA vs JNJ

PZA vs JNJ: Dividend Comparison 2026

PZA yields 3.65% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $4.9K in total portfolio value· pulled ahead in Year 9
10 years
PZA
PZA
● Live price
3.65%
Share price
$22.98
Annual div
$0.84
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$462.07
Full PZA calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PZA vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPZAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PZA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PZA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PZA
Annual income on $10K today (after 15% tax)
$310.55/yr
After 10yr DRIP, annual income (after tax)
$392.76/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,593.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PZA + JNJ for your $10,000?

PZA: 50%JNJ: 50%
100% JNJ50/50100% PZA
Portfolio after 10yr
$27.8K
Annual income
$2,575.73/yr
Blended yield
9.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PZA
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PZA buys
0
JNJ buys
0
No recent congressional trades found for PZA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPZAJNJ
Forward yield3.65%2.13%
Annual dividend / share$0.84$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$25.3K$30.3K
Annual income after 10y$462.07$4,689.40
Total dividends collected$4.2K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PZA vs JNJ ($10,000, DRIP)

YearPZA PortfolioPZA Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,065$365.35$10,592$272.30+$473.00PZA
2$12,218$377.83$11,289$357.73+$929.00PZA
3$13,463$389.88$12,123$472.89+$1.3KPZA
4$14,807$401.51$13,141$629.86+$1.7KPZA
5$16,256$412.70$14,408$846.81+$1.8KPZA
6$17,817$423.45$16,021$1,151.60+$1.8KPZA
7$19,498$433.76$18,122$1,588.22+$1.4KPZA
8$21,307$443.63$20,930$2,228.20+$377.00PZA
9← crossover$23,251$453.07$24,792$3,191.91$1.5KJNJ
10$25,341$462.07$30,274$4,689.40$4.9KJNJ

PZA vs JNJ: Complete Analysis 2026

PZAStock

The Invesco National AMT-Free Municipal Bond ETF (Fund) is based on The ICE BofAML National Long-Term Core Plus Municipal Securities Index (Index). The Fund generally will invest at least 80% of its total assets in municipal securities that comprise the Index and that also are exempt from the federal alternative minimum tax. The Index is composed of US dollar-denominated, investment grade, tax-exempt debt publicly issued by US. states and territories, or their political subdivisions, in the US domestic market with a term of at least 15 years remaining to final maturity. The Index is adjusted monthly and its constituents are capitalization-weighted based on their current amount outstanding. The Fund does not purchase all of the securities in the Index; instead, the Fund utilizes a "sampling" methodology to seek to achieve its investment objective. The Fund and the Index are rebalanced and reconstituted monthly.

Full PZA Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PZA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PZA vs SCHDPZA vs JEPIPZA vs OPZA vs KOPZA vs MAINPZA vs ABBVPZA vs MRKPZA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.